
Number of publications published per year by Sangro, Bruno. (Source : PubMed)

Distribution of publications types for Sangro, Bruno. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.
Eur J Gastroenterol Hepatol
2010;22;4

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.
Hepatogastroenterology
2009;56;96
Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report.
Clin Transplant
2009;23;4


Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.
Dig. Dis. Sci.
2009;54;5


Spontaneous regression of hepatocellular carcinoma: a systematic review.
Eur J Gastroenterol Hepatol
2009;21;3

[Diagnosis and treatment of hepatocellular carcinoma]
Med Clin (Barc)
2009;132;7
Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Cancer Res.
2009;69;4

Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres.
Dig Dis
2009;27;2
Liver disease induced by radioembolization of liver tumors: description and possible risk factors.
Cancer
2008;112;7

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
Liver Transpl.
2008;14;3
[ See timeline ] [ See all publications ]
means that Sangro, Bruno has 28 papers cited a least 28 times - methodology
Liver Unit, Clinica Universitaria, Pamplona, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.